Psychopharmacology

, Volume 174, Issue 4, pp 452–462 | Cite as

Heritable differences in the dopaminergic regulation of sensorimotor gating

II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition
  • Neal R. Swerdlow
  • Jody M. Shoemaker
  • Pamela P. Auerbach
  • Leia Pitcher
  • Jana Goins
  • Amanda Platten
Original Investigation

Abstract

Rationale and objectives

The disruption of prepulse inhibition (PPI) of startle in rats by dopamine agonists has been used in a predictive model for antipsychotics, and more recently, to study the neural basis of strain differences in dopaminergic function. We have previously reported that Sprague-Dawley (SDH) and Long Evans (LEH) rats differed in their sensitivity to the PPI-disruptive effects of the D1/D2 agonist apomorphine (APO) in two distinct ways: 1) compared to LEH rats, SDH rats were more sensitive to the ability of APO to disrupt PPI with relatively long prepulse intervals (60–120 ms), and 2) APO enhanced PPI in LEH rats with 10–30 ms prepulse intervals, but this effect was limited to 10 ms prepulse intervals in SDH rats.

Methods

In the present study, we replicated this temporal profile in SDH versus LEH rats, assessed the role of D1 versus D2 substrates in the two components of this strain difference, and assessed the heritability of these temporally distinct processes.

Results

Pharmacologic studies revealed that: 1) D2 blockade prevented the long interval PPI-disruptive effects of APO in both strains, and extended the temporal range of the PPI-enhancing effects of APO from 10 to 30 ms in SDH rats, and 2) D1 blockade increased PPI and blocked the PPI-enhancing effects of APO at short intervals in both strains. Generational studies in adult F0 (SDH and LEH), F1 (SDHxLEH) and N2 (SDHxF1) rats demonstrated that sensitivity to APO of both short and long interval PPI were inherited in a manner suggestive of relatively simple additive effects of multiple genes.

Conclusions

The present findings demonstrate that inherited differences in the dopaminergic regulation of sensorimotor gating are manifested not only in quantitative shifts (more versus less), but also in qualitative shifts in the temporal properties of sensorimotor gating that appear to be under separate control of D1 and D2 substrates.

Keywords

Apomorphine Dopamine Genetics Prepulse inhibition Schizophrenia Startle 

Notes

Acknowledgements

This study was supported by National Institute of Mental Health awards MH58384, MH01436 & MH42228. The authors are grateful for the assistance of Ms. Sarah Crain in the preparation of this manuscript.

References

  1. Abduljawad KAJ, Langley RW, Bradshaw CM, Szabadi E (1997) Evidence for involvement of D2 dopamine receptors in prepulse inhibition of the startle reflex in man. Psychopharmacology 11:69Google Scholar
  2. Amicarelli F, Gasbarri A, Masciocco L, Pompili A, Pacitti C, Carlucci G, Palumbo G, Miranda M (1999) The effect of intrastriatal injection of liposome-entrapped tyrosinase on the dopamine levels in the rat brain. Cell Mol Biol 45:1093–1097Google Scholar
  3. Braff DL, Freedman R (2002) The importance of endophenotypes in studies of the genetics of schizophrenia. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress. Lippincott, Williams & Wilkins, Baltimore, pp 703–716Google Scholar
  4. Braff DL, Stone C, Callaway E, Geyer MA, Glick ID, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: 339–343PubMedGoogle Scholar
  5. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234–258PubMedGoogle Scholar
  6. Buzsaki G, Smith A, Berger S, Fisher LJ, Gage FH (1990) Petit mal epilepsy and parkinsonian tremor: hypothesis of a common pacemaker. Neuroscience 36:1–14CrossRefPubMedGoogle Scholar
  7. Carter RJ, Lione LA, Humby T et al. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19:3248–3257PubMedGoogle Scholar
  8. de Bruin NMWJ, van Luijtelaar ELJM, Jansen SJ, Cools AR, Ellenbroek BA (2000) Dopamine characteristics in different rat genotypes: the relation to absence epilepsy. Neurosci Res 38:165–173CrossRefPubMedGoogle Scholar
  9. de Bruin NM, van Luijtelaar EL, Cools AR, Ellenbroek BA (2001) Auditory information processing in rat genotypes with different dopaminergic properties. Psychopharmacology 156:352–359CrossRefPubMedGoogle Scholar
  10. Geyer MA, Swerdlow NR (1998) Measurement of startle response, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P (eds) current protocols in neuroscience. Wiley, New York, pp 8.7.1–8.7.15Google Scholar
  11. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117–154PubMedGoogle Scholar
  12. Graham F (1975) The more or less startling effects of weak prestimuli. Psychophysiology 12:238–248PubMedGoogle Scholar
  13. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32:939–943PubMedGoogle Scholar
  14. Hutchison KE, Swift R (1999) Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology 156:165–168Google Scholar
  15. Kinney GG, Wilkinson LO, Saywell KL, Tricklebank MD (1999) Rat strain differences in ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci 19:5644–5653PubMedGoogle Scholar
  16. Kumari V, Soni W, Sharma T (1999) Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156:1046–1051PubMedGoogle Scholar
  17. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507–514PubMedGoogle Scholar
  18. Martin-Iverson MT, Else D (2000) PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats. Psychopharmacology 151:38–48PubMedGoogle Scholar
  19. Meloni EG, Davis M (1999) Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958. Psychopharmacology 144:373–380Google Scholar
  20. Palmer AA, Dulawa SC, Mottiwala AA, Conti LH, Geyer MA, Printz MP (2000) Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci 114:374–388PubMedGoogle Scholar
  21. Peng RY, Mansbach RS, Braff DL, Geyer MA (1991) A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology 3:211–218Google Scholar
  22. Rigdon G (1990) Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology 102:419–421PubMedGoogle Scholar
  23. Searle AG (1990) Comparative genetics of albinism. Ophth Paediatr Genet 11:159–164Google Scholar
  24. Swerdlow NR (1996) Cortico-striatal substrates of cognitive, motor and sensory gating: speculations and implications for psychological function and dysfunction. In: Panksepp L (ed) Advances in biological psychiatry (vol 2). JAI Press, Greenwich, Conn., pp 179–208Google Scholar
  25. Swerdlow NR, Geyer MA, Braff DL, Koob GF (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiatry 21:23–33PubMedGoogle Scholar
  26. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139–154PubMedGoogle Scholar
  27. Swerdlow NR, Braff DL, Geyer MA (2000a) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185–204PubMedGoogle Scholar
  28. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA (2000b) Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20:4325–4336PubMedGoogle Scholar
  29. Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach PP (2001a) Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology 158:230–240CrossRefPubMedGoogle Scholar
  30. Swerdlow NR, Platten A, Kim YK, Gaudet I, Shoemaker J, Pitcher L, Auerbach P (2001b) Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants. Pharmacol Biochem Behav 70:219–226CrossRefPubMedGoogle Scholar
  31. Swerdlow NR, Shoemaker JM, Pitcher L, Platten A, Kuczenski R, Eeley CC, Auerbach P (2002) Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Behav Neurosci 116:682–690CrossRefPubMedGoogle Scholar
  32. Swerdlow NR, Platten A, Hanlon FM, Martinez ZA, Printz MP, Auerbach P (2003a) Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology 28:226–234CrossRefPubMedGoogle Scholar
  33. Swerdlow NR, Shoemaker JM, Auerbach PP, Pitcher L, Goins J, Platten A (2003b) Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharmacology DOI 10.1007/s00213-003-1481-3Google Scholar
  34. Tief K, Schmidt A, Beermann F (1998) New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. Brain Res Mol Brain Res 53:307–310CrossRefPubMedGoogle Scholar
  35. Wan FJ, Taaid N, Swerdlow NR (1996) Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology 14:265–274Google Scholar
  36. Weike AI, Bauer U, Hamm AO (2000) Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 47:61–70PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Neal R. Swerdlow
    • 1
  • Jody M. Shoemaker
    • 1
  • Pamela P. Auerbach
    • 1
  • Leia Pitcher
    • 1
  • Jana Goins
    • 1
  • Amanda Platten
    • 1
  1. 1.Department of PsychiatryUCSD School of MedicineLa JollaUSA

Personalised recommendations